A breakout from biomedical issue Alkermes (ALKS) has fizzled, thanks to the market's turn for the worse. Another drug company with operations in Ireland, Jazz Pharmaceuticals (JAZZ), is in much better shape. Alkermes ended Wednesday below its 50-day moving average for the fourth straight day and is on track to post its third straight weekly loss. That's not what one would have expected Sept. 20, when it broke out from a flat base. By the time the